Predictors for radiological damage in psoriatic arthritis: results from a single centre

被引:118
作者
Bond, Simon J.
Farewell, Vernon T.
Schentag, Catherine T.
Gladman, Dafna D.
机构
[1] Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis, Psoriat Arthritis Program, Toronto, ON M5T 2S8, Canada
[2] Inst Publ Hlth, MRC Biostat Unit, Cambridge, England
[3] Univ Toronto, Toronto Western Res Inst, Toronto, ON, Canada
基金
英国医学研究理事会;
关键词
D O I
10.1136/ard.2006.056457
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The predictors for the development of clinical damage in psoriatic arthritis (PsA) have been reported previously. Aim: To identify predictors for radiological damage in PsA. Methods: Patients followed-up prospectively according to a standard protocol at The University of Toronto between 1978 and 2004 were included. The principal outcome was the change in the number of damaged joints between visits, both clinically and radiologically. Explanatory variables considered included: sex, age, duration of arthritis at first visit, time in clinic, number of tender swollen joints, functional class, erythrocyte sedimentation rate (ESR), concentration of drugs and, to adjust for within-patient correlation, the number of clinically damaged joints at the first of the two visits over which change was observed. Results: At the time of this analysis, 625 patients were recorded in the database. Multivariate analyses of predictors for both clinical and radiological damage show that age, time in clinic, initial ESR, number of tender and swollen joints at previous visit, and number of deformed joints at previous visit were related to both clinical and radiological damage. Conclusions: The number of actively inflamed joints, particularly the number of swollen joints, was associated with the progression of radiological damage. The higher the number of previously damaged joints, the higher the risk for progression of damage. Thus, patients with PsA need to be treated, even in the presence of damage as long as there is evidence of inflammation, to prevent the progression of damage.
引用
收藏
页码:370 / 376
页数:7
相关论文
共 17 条
[1]  
GLADMAN DD, 1995, J RHEUMATOL, V22, P675
[2]  
Gladman DD, 1998, ARTHRITIS RHEUM-US, V41, P1103, DOI 10.1002/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO
[3]  
2-N
[4]  
Gladman DD, 1999, J RHEUMATOL, V26, P2409
[5]  
Gladman DD, 2004, J RHEUMATOL, V31, P1126
[6]   NATURAL-HISTORY OF PSORIATIC-ARTHRITIS [J].
GLADMAN, DD .
BAILLIERES CLINICAL RHEUMATOLOGY, 1994, 8 (02) :379-394
[7]  
GLADMAN DD, 1987, Q J MED, V62, P127
[8]  
GLADMAN DD, 1990, J RHEUMATOL, V17, P62
[9]  
GLADMAN DD, 2004, PSORIATIC ARTHRITIS, P766
[10]   A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience [J].
Kane, D ;
Stafford, L ;
Bresnihan, B ;
FitzGerald, O .
RHEUMATOLOGY, 2003, 42 (12) :1460-1468